Developer docs
API playgroundTry for free, no card

Search company profiles

Genes Laboratories

Full company profile

uuid000wgbu

Namestring
Genes Laboratories
Legal namestring
주식회사 진스랩
Websiteurl
geneslabs.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Genes Laboratories (진스랩) is a South Korea-based molecular diagnostics company founded on November 4, 2008, with headquarters in Seongnam-si, Gyeonggi-do, and an additional R&D facility in Yongin-si. The company develops, manufactures, and commercializes PCR-based diagnostic kits and reagents across three brand families: GCdia™ human diagnostic kits covering infectious diseases (respiratory infections, sexually transmitted infections, gastrointestinal infections, pneumonia, hepatitis, tuberculosis), genetic disorders (HLA typing for transplant compatibility and disease association, ApoE genotyping for Alzheimer's risk), and pharmacogenomics (HLA-B*58:01 for drug hypersensitivity); GCani™ veterinary diagnostic kits for canine and feline companion animal diseases plus zoonotic pathogens (SFTSV, Babesia, Salmonella); and NEXpro™/NEXscript™ brand PCR enzymes, master mixes, and reverse-transcription reagents sold to other diagnostic manufacturers and research institutions.

The company's technology platform centers on multiplex quantitative real-time PCR (qPCR) and qRT-PCR using fluorescent probe-based detection, supported by proprietary enzyme chemistry including a monoclonal antibody-based hot-start Taq DNA polymerase (NEXpro™ HS Taq) and a UDG-containing qRT-PCR master mix designed to suppress non-specific amplification. As of 2023 the company held over 10 patents, had a 12-product development pipeline, and maintained 25+ export approvals for animal and zoonotic diagnostic reagents, three MFDS-approved genetic disease kits, and certifications including ISO 13485, KGMP, ISO 9001, GMP, and European CE Mark (for COVID-19 reagents).

Genes Laboratories has been part of the GC Green Cross (GC녹십자) healthcare conglomerate family since 2021, operating as the group's designated molecular diagnostics representative. It sells primarily through direct sales to hospitals, clinical diagnostic laboratories, and veterinary clinics, supplemented by international export channels and a November 2025 domestic distribution agreement with Inpeco for Total Laboratory Automation (TLA) solutions. Pricing is not publicly disclosed. Revenue is not disclosed in source data; with 1-10 employees per firmographics, the company operates a lean team despite its broad product portfolio. Current CEO Woo Byeong-ho (우병호) was appointed in 2024 following the resignation of Jang Uk-jin (장욱진).

Short descriptiontext

Genes Laboratories is a South Korean molecular diagnostics company developing PCR-based kits for human infectious and genetic diseases, companion animal diagnostics, and PCR reagents, operating as the molecular diagnostics arm of GC Green Cross.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersYongin, South Korea
HQ citystring
Yongin
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics kits, PCR diagnostic reagents, veterinary diagnostic kits, infectious disease testing, PCR enzymes and master mixes
Industry4 codes
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical Laboratories621511
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
Product category
Molecular Diagnostics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Human Diagnostic Kits
TypeOne Time License
Description

Sale of multiplex qPCR detection kits for human infectious diseases (respiratory infections, sexually transmitted infections, gastrointestinal infections, tuberculosis, pneumonia) and genetic disorders (HLA typing, ApoE genotyping). Revenue from regulatory-approved in vitro diagnostic medical devices sold domestically (MFDS-approved) and for export.

geneslabs.com
2Veterinary Diagnostic Kits
TypeOne Time License
Description

Sale of multiplex qPCR/qRT-PCR detection kits for companion animals (dogs and cats) and zoonotic diseases, including products for export to multiple countries. Veterinary medical device sales.

geneslabs.com
3PCR Raw Materials and Reagents
TypeOne Time License
Description

Sale of PCR enzymes, master mixes, and nucleic acid extraction kits to other diagnostic manufacturers and laboratories. Global supply of molecular diagnostic-grade raw materials including DNA polymerases, reverse transcriptases, and optimized buffer systems.

geneslabs.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1GCdia™
Description

Human diagnostics product brand for infectious and genetic disease molecular diagnostic kits including GCdia™ MTB/NTM Real-Time PCR Kit, GCdia™ HLA-B27, GCdia™ ApoE Genotyping Kit, GCdia™ Pneumocystis jirovecii Real-Time PCR Kit, and others.

geneslabs.com
+3 more records
Core offering1 text field

Genes Laboratories develops, manufactures, and commercializes PCR-based molecular diagnostic kits and reagents. Its portfolio spans three lines: GCdia™ human diagnostic kits (respiratory, sexually transmitted, gastrointestinal, pneumonia, hepatitis, tuberculosis, and genetic disease panels such as HLA typing and ApoE genotyping), GCani™ companion-animal and zoonotic diagnostic kits for canines, felines, and zoonotic pathogens (SFTSV, Babesia, Salmonella), and NEXpro™/NEXscript™ brand PCR raw materials (DNA polymerases, hot-start Taq, reverse transcriptases, master mixes, and nucleic extraction reagents) sold to other diagnostic manufacturers and research labs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 25+ animal and zoonotic disease diagnostic reagents received export approval in 2023, enabling international market presence
+2 more records
Product overview1 text field

Genes Laboratories is a molecular diagnostics company that develops, manufactures, and commercializes PCR-based diagnostic kits for human infectious diseases, genetic diseases, veterinary (companion animal and zoonotic) diseases, and PCR reagents/raw materials. The product portfolio includes three main product lines: (1) GCdia™ brand human diagnostic kits covering infectious diseases (respiratory infections, sexually transmitted infections, gastrointestinal infections, tuberculosis, pneumonia), genetic diseases (HLA typing for transplant compatibility, ApoE genotyping for Alzheimer's disease), and pharmacogenomics (HLA-B*58:01); (2) GCani™ brand veterinary diagnostic kits for canine and feline diseases across gastrointestinal, hematological, respiratory, and neurological categories, plus zoonotic pathogens (SFTSV, Babesia, Salmonella); and (3) NEXpro™ and NEXscript™ brand PCR reagents and enzymes for research and diagnostic manufacturing applications. The company also offers diagnostic systems including lab automation equipment, point-of-care testing devices, and a mobile diagnostic laboratory (GCdia Mobile Base Camp). All products are based on molecular diagnostic technologies including conventional PCR, real-time PCR (qPCR), RT-PCR, and qRT-PCR using fluorescent probe-based detection methods.

Product and service9 records
1GCdia™ Human Infectious Disease Real-Time PCR Kits
CategoryHuman Diagnostics — Infectious Disease
Description

Multiplex real-time PCR kits for qualitative detection of human infectious disease pathogens from clinical specimens such as sputum, nasopharyngeal swabs, blood, urine, and tissue samples. Intended for hospitals and clinical diagnostic laboratories.

2GCdia™ Human Genetic Disease Real-Time PCR Kits
CategoryHuman Diagnostics — Genetic Disease
Description

Real-time PCR kits for HLA typing for transplant compatibility and pharmacogenomics (HLA-B27, HLA-B51, HLA-B*58:01 for allopurinol hypersensitivity), and ApoE genotyping for Alzheimer's disease and cardiovascular risk. Sold to clinical labs and hospitals.

3GCani™ Canine Disease Multiplex qPCR/qRT-PCR Detection Kits
CategoryVeterinary Diagnostics — Canine
Description

Multiplex real-time PCR kits for qualitative detection of canine pathogens causing diarrhea (bacterial and viral panels), anemia (bacterial panels), respiratory infections, and neurological diseases. Used by veterinary hospitals and animal diagnostic laboratories.

4GCani™ Feline Disease Multiplex qPCR/qRT-PCR Detection Kits
CategoryVeterinary Diagnostics — Feline
Description

Multiplex real-time PCR kits for qualitative detection of feline pathogens causing diarrhea, anemia, respiratory infections, neurological disease, and Feline Coronavirus (FCoV). Used by veterinary hospitals and animal diagnostic laboratories.

5GCani™ Zoonotic Disease Detection Kits
CategoryVeterinary Diagnostics — Zoonotic Disease
Description

Multiplex real-time PCR kits for detection of zoonotic pathogens including Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), Babesia species, and Salmonella in animal samples. Used by veterinary clinics and public health/animal health laboratories.

6NEXpro™ PCR Enzymes and Master Mixes
CategoryPCR Reagents — Enzymes and Master Mixes
Description

PCR enzymes and ready-to-use 2X master mixes for conventional PCR, real-time PCR, and qRT-PCR applications. Hot-start Taq formulations with monoclonal antibody inhibition reduce non-specific amplification. Sold to diagnostic kit manufacturers, biotech firms, and research laboratories globally.

7NEXscript™ Reverse Transcription and RT-PCR Reagents
CategoryPCR Reagents — Reverse Transcription
Description

Reverse transcription master mixes and one-step RT-PCR reagents for cDNA synthesis from RNA templates. Includes formulations with Oligo dT primers, random hexamers, and combined RT-PCR with fluorescent dye. Sold to diagnostic manufacturers and research labs.

8Diagnostic Systems (Point-of-Care and Lab Automation)
CategoryDiagnostic Systems and Instrumentation
Description

Hardware diagnostic systems comprising a mobile diagnostic laboratory (GCdia Mobile Base Camp), production and extraction automation equipment, and a point-of-care molecular diagnostic testing device for rapid bedside or field diagnosis.

9COVID-19 Diagnostic Reagent
CategoryHuman Diagnostics — Infectious Disease (Respiratory)
Description

Real-time PCR kit (GCdia™ COVID-19 Fast Detection Kit) for detection of two target genes of SARS-CoV-2 from nasopharyngeal swab, oropharyngeal swab, and sputum samples. CE-Marked for export and MFDS-approved domestically.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-05
Description

Genes Laboratories signed an official domestic distribution agreement with Inpeco in November 2025. Inpeco serves as the official distributor for TLA (Total Laboratory Automation) solutions and provides associated technical support to customers in South Korea.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

US-headquartered molecular diagnostics incumbent with Panther Fusion menu covering respiratory, STI, and other infectious disease targets; broad incumbent competitor in clinical molecular testing.

TypeBroad incumbent
Description

Global leader in molecular diagnostics and PCR enzymes/reagents; competes with Genes Laboratories' NEXpro™/NEXscript™ raw materials offering and broader IVD menu, but at much larger scale and global reach.

TypeBroad incumbent
Description

Global IVD incumbent with extensive molecular diagnostics portfolio (cobas, LightCycler); competes broadly with Genes Laboratories in clinical lab infectious disease and genetic testing markets.

TypeBroad incumbent
Description

Leader in automated molecular diagnostics (GeneXpert) with broad infectious disease menu; competing incumbent for hospital and lab customers targeted by Genes Laboratories' multiplex qPCR kits.

TypeBroad incumbent
Description

Global molecular diagnostics player via BioFire FilmArray syndromic panels; competes with Genes Laboratories in multiplex infectious disease testing for clinical laboratories.

6Kogene Biotech
TypeDirect peer
Description

Korean PCR-based IVD developer offering infectious disease diagnostic kits and reagents; directly comparable product categories (respiratory, STI, GI) and Korean regulatory positioning.

TypeDirect peer
Description

Korean molecular diagnostics company specializing in multiplex qPCR reagents and syndromic panels for infectious disease and genetic testing — directly comparable technology stack and customer base (clinical labs and hospitals) to Genes Laboratories.

TypeDirect peer
Description

Korean in-vitro diagnostics company offering molecular (PCR) and rapid antigen kits for infectious diseases with strong export footprint; comparable IVD product lines and channel approach.

TypeDirect peer
Description

Korean molecular diagnostics manufacturer of qPCR/RT-PCR kits for infectious disease and genetic testing; comparable multiplex assay technology and IVD regulatory profile in Korea.

TypeEmerging player
Description

Korean molecular diagnostics and life science tools company with PCR instruments and AccuPower reagent kits; comparable Asian footprint and reagent product lines to Genes Laboratories.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genes Laboratories

Molecular Diagnosticsgeneslabs.com

Genes Laboratories is a South Korean molecular diagnostics company developing PCR-based kits for human infectious and genetic diseases, companion animal diagnostics, and PCR reagents, operating as the molecular diagnostics arm of GC Green Cross.

What Genes Laboratories does

Genes Laboratories (진스랩) is a South Korea-based molecular diagnostics company founded on November 4, 2008, with headquarters in Seongnam-si, Gyeonggi-do, and an additional R&D facility in Yongin-si. The company develops, manufactures, and commercializes PCR-based diagnostic kits and reagents across three brand families: GCdia™ human diagnostic kits covering infectious diseases (respiratory infections, sexually transmitted infections, gastrointestinal infections, pneumonia, hepatitis, tuberculosis), genetic disorders (HLA typing for transplant compatibility and disease association, ApoE genotyping for Alzheimer's risk), and pharmacogenomics (HLA-B*58:01 for drug hypersensitivity); GCani™ veterinary diagnostic kits for canine and feline companion animal diseases plus zoonotic pathogens (SFTSV, Babesia, Salmonella); and NEXpro™/NEXscript™ brand PCR enzymes, master mixes, and reverse-transcription reagents sold to other diagnostic manufacturers and research institutions.

The company's technology platform centers on multiplex quantitative real-time PCR (qPCR) and qRT-PCR using fluorescent probe-based detection, supported by proprietary enzyme chemistry including a monoclonal antibody-based hot-start Taq DNA polymerase (NEXpro™ HS Taq) and a UDG-containing qRT-PCR master mix designed to suppress non-specific amplification. As of 2023 the company held over 10 patents, had a 12-product development pipeline, and maintained 25+ export approvals for animal and zoonotic diagnostic reagents, three MFDS-approved genetic disease kits, and certifications including ISO 13485, KGMP, ISO 9001, GMP, and European CE Mark (for COVID-19 reagents).

Genes Laboratories has been part of the GC Green Cross (GC녹십자) healthcare conglomerate family since 2021, operating as the group's designated molecular diagnostics representative. It sells primarily through direct sales to hospitals, clinical diagnostic laboratories, and veterinary clinics, supplemented by international export channels and a November 2025 domestic distribution agreement with Inpeco for Total Laboratory Automation (TLA) solutions. Pricing is not publicly disclosed. Revenue is not disclosed in source data; with 1-10 employees per firmographics, the company operates a lean team despite its broad product portfolio. Current CEO Woo Byeong-ho (우병호) was appointed in 2024 following the resignation of Jang Uk-jin (장욱진).

Genes Laboratories firmographics

Firmographics
Name
Genes Laboratories
Legal name
주식회사 진스랩
Website
https://geneslabs.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
1–10 employees
Short description
Genes Laboratories is a South Korean molecular diagnostics company developing PCR-based kits for human infectious and genetic diseases, companion animal diagnostics, and PCR reagents, operating as the molecular diagnostics arm of GC Green Cross.
Ownership category
akta.pro rank

Genes Laboratories industry classification

Industry
Product category
Molecular Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Molecular diagnostics kits
  • PCR diagnostic reagents
  • Veterinary diagnostic kits
  • Infectious disease testing
  • PCR enzymes and master mixes

Where Genes Laboratories is headquartered

Location

Headquarters

HQ city
Yongin
HQ country
South Korea
HQ region
Asia

Offices2 records

Markets served

Genes Laboratories business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Human Diagnostic Kits: Sale of multiplex qPCR detection kits for human infectious diseases (respiratory infections, sexually transmitted infections, gastrointestinal infections, tuberculosis, pneumonia) and genetic disorders (HLA typing, ApoE genotyping). Revenue from regulatory-approved in vitro diagnostic medical devices sold domestically (MFDS-approved) and for export.
  2. Veterinary Diagnostic Kits: Sale of multiplex qPCR/qRT-PCR detection kits for companion animals (dogs and cats) and zoonotic diseases, including products for export to multiple countries. Veterinary medical device sales.
  3. PCR Raw Materials and Reagents: Sale of PCR enzymes, master mixes, and nucleic acid extraction kits to other diagnostic manufacturers and laboratories. Global supply of molecular diagnostic-grade raw materials including DNA polymerases, reverse transcriptases, and optimized buffer systems.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Genes Laboratories product offering

Product offering

Core offering

Genes Laboratories develops, manufactures, and commercializes PCR-based molecular diagnostic kits and reagents. Its portfolio spans three lines: GCdia™ human diagnostic kits (respiratory, sexually transmitted, gastrointestinal, pneumonia, hepatitis, tuberculosis, and genetic disease panels such as HLA typing and ApoE genotyping), GCani™ companion-animal and zoonotic diagnostic kits for canines, felines, and zoonotic pathogens (SFTSV, Babesia, Salmonella), and NEXpro™/NEXscript™ brand PCR raw materials (DNA polymerases, hot-start Taq, reverse transcriptases, master mixes, and nucleic extraction reagents) sold to other diagnostic manufacturers and research labs.

Product overview

Genes Laboratories is a molecular diagnostics company that develops, manufactures, and commercializes PCR-based diagnostic kits for human infectious diseases, genetic diseases, veterinary (companion animal and zoonotic) diseases, and PCR reagents/raw materials. The product portfolio includes three main product lines: (1) GCdia™ brand human diagnostic kits covering infectious diseases (respiratory infections, sexually transmitted infections, gastrointestinal infections, tuberculosis, pneumonia), genetic diseases (HLA typing for transplant compatibility, ApoE genotyping for Alzheimer's disease), and pharmacogenomics (HLA-B*58:01); (2) GCani™ brand veterinary diagnostic kits for canine and feline diseases across gastrointestinal, hematological, respiratory, and neurological categories, plus zoonotic pathogens (SFTSV, Babesia, Salmonella); and (3) NEXpro™ and NEXscript™ brand PCR reagents and enzymes for research and diagnostic manufacturing applications. The company also offers diagnostic systems including lab automation equipment, point-of-care testing devices, and a mobile diagnostic laboratory (GCdia Mobile Base Camp). All products are based on molecular diagnostic technologies including conventional PCR, real-time PCR (qPCR), RT-PCR, and qRT-PCR using fluorescent probe-based detection methods.

Differentiator

Problem solved

Functional benefit

Brands

  • GCdia™: Human diagnostics product brand for infectious and genetic disease molecular diagnostic kits including GCdia™ MTB/NTM Real-Time PCR Kit, GCdia™ HLA-B27, GCdia™ ApoE Genotyping Kit, GCdia™ Pneumocystis jirovecii Real-Time PCR Kit, and others.
  • GCani™
  • NEXpro™
  • NEXscript™

Products and services

  • GCdia™ Human Infectious Disease Real-Time PCR Kits Multiplex real-time PCR kits for qualitative detection of human infectious disease pathogens from clinical specimens such as sputum, nasopharyngeal swabs, blood, urine, and tissue samples. Intended for hospitals and clinical diagnostic laboratories.
  • GCdia™ Human Genetic Disease Real-Time PCR Kits Real-time PCR kits for HLA typing for transplant compatibility and pharmacogenomics (HLA-B27, HLA-B51, HLA-B*58:01 for allopurinol hypersensitivity), and ApoE genotyping for Alzheimer's disease and cardiovascular risk. Sold to clinical labs and hospitals.
  • GCani™ Canine Disease Multiplex qPCR/qRT-PCR Detection Kits Multiplex real-time PCR kits for qualitative detection of canine pathogens causing diarrhea (bacterial and viral panels), anemia (bacterial panels), respiratory infections, and neurological diseases. Used by veterinary hospitals and animal diagnostic laboratories.
  • GCani™ Feline Disease Multiplex qPCR/qRT-PCR Detection Kits Multiplex real-time PCR kits for qualitative detection of feline pathogens causing diarrhea, anemia, respiratory infections, neurological disease, and Feline Coronavirus (FCoV). Used by veterinary hospitals and animal diagnostic laboratories.
  • GCani™ Zoonotic Disease Detection Kits Multiplex real-time PCR kits for detection of zoonotic pathogens including Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), Babesia species, and Salmonella in animal samples. Used by veterinary clinics and public health/animal health laboratories.
  • NEXpro™ PCR Enzymes and Master Mixes PCR enzymes and ready-to-use 2X master mixes for conventional PCR, real-time PCR, and qRT-PCR applications. Hot-start Taq formulations with monoclonal antibody inhibition reduce non-specific amplification. Sold to diagnostic kit manufacturers, biotech firms, and research laboratories globally.
  • NEXscript™ Reverse Transcription and RT-PCR Reagents Reverse transcription master mixes and one-step RT-PCR reagents for cDNA synthesis from RNA templates. Includes formulations with Oligo dT primers, random hexamers, and combined RT-PCR with fluorescent dye. Sold to diagnostic manufacturers and research labs.
  • Diagnostic Systems (Point-of-Care and Lab Automation) Hardware diagnostic systems comprising a mobile diagnostic laboratory (GCdia Mobile Base Camp), production and extraction automation equipment, and a point-of-care molecular diagnostic testing device for rapid bedside or field diagnosis.
  • COVID-19 Diagnostic Reagent Real-time PCR kit (GCdia™ COVID-19 Fast Detection Kit) for detection of two target genes of SARS-CoV-2 from nasopharyngeal swab, oropharyngeal swab, and sputum samples. CE-Marked for export and MFDS-approved domestically.

Quantifiable outcome

  • 25+ animal and zoonotic disease diagnostic reagents received export approval in 2023, enabling international market presence
  • +2 more outcomes

Companies that use Genes Laboratories

Customer profile

Segments3 records

Ideal customer profiles3 records

Genes Laboratories technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Genes Laboratories partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Inpeco (인페코)coreChannel Partner/ Reseller/ Distributor · 5 November 2025Genes Laboratories signed an official domestic distribution agreement with Inpeco in November 2025. Inpeco serves as the official distributor for TLA (Total Laboratory Automation) solutions and provides associated technical support to customers in South Korea.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Genes Laboratories competitors and assessment

Company assessment

Broad incumbents

  • Hologic (Panther Fusion): US-headquartered molecular diagnostics incumbent with Panther Fusion menu covering respiratory, STI, and other infectious disease targets; broad incumbent competitor in clinical molecular testing.
  • Qiagen: Global leader in molecular diagnostics and PCR enzymes/reagents; competes with Genes Laboratories' NEXpro™/NEXscript™ raw materials offering and broader IVD menu, but at much larger scale and global reach.
  • Roche Diagnostics: Global IVD incumbent with extensive molecular diagnostics portfolio (cobas, LightCycler); competes broadly with Genes Laboratories in clinical lab infectious disease and genetic testing markets.
  • Cepheid (Danaher): Leader in automated molecular diagnostics (GeneXpert) with broad infectious disease menu; competing incumbent for hospital and lab customers targeted by Genes Laboratories' multiplex qPCR kits.
  • bioMérieux (BioFire): Global molecular diagnostics player via BioFire FilmArray syndromic panels; competes with Genes Laboratories in multiplex infectious disease testing for clinical laboratories.

Direct peers

  • Kogene Biotech: Korean PCR-based IVD developer offering infectious disease diagnostic kits and reagents; directly comparable product categories (respiratory, STI, GI) and Korean regulatory positioning.
  • Seegene: Korean molecular diagnostics company specializing in multiplex qPCR reagents and syndromic panels for infectious disease and genetic testing — directly comparable technology stack and customer base (clinical labs and hospitals) to Genes Laboratories.
  • SD Biosensor: Korean in-vitro diagnostics company offering molecular (PCR) and rapid antigen kits for infectious diseases with strong export footprint; comparable IVD product lines and channel approach.
  • SolGent (SolGent Daejeon): Korean molecular diagnostics manufacturer of qPCR/RT-PCR kits for infectious disease and genetic testing; comparable multiplex assay technology and IVD regulatory profile in Korea.

Emerging players

  • Bioneer: Korean molecular diagnostics and life science tools company with PCR instruments and AccuPower reagent kits; comparable Asian footprint and reagent product lines to Genes Laboratories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Genes Laboratories social profiles

Digital presence

Genes Laboratories compliance and trust

Trust signal

Compliance5 records

Genes Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genes Laboratories leadership team

Management profile

Number of profiles

Profiles1 record

Genes Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genes Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genes Laboratories

What does Genes Laboratories do?

Genes Laboratories develops, manufactures, and commercializes PCR-based molecular diagnostic kits and reagents. Its portfolio spans three lines: GCdia™ human diagnostic kits (respiratory, sexually transmitted, gastrointestinal, pneumonia, hepatitis, tuberculosis, and genetic disease panels such as HLA typing and ApoE genotyping), GCani™ companion-animal and zoonotic diagnostic kits for canines, felines, and zoonotic pathogens (SFTSV, Babesia, Salmonella), and NEXpro™/NEXscript™ brand PCR raw materials (DNA polymerases, hot-start Taq, reverse transcriptases, master mixes, and nucleic extraction reagents) sold to other diagnostic manufacturers and research labs.

Is Genes Laboratories a public or private company?

Genes Laboratories is a private company. It is classified as corporate owned and is currently operating.

When was Genes Laboratories founded?

Genes Laboratories was founded in 2008. It employs 1 to 10 people.

Where is Genes Laboratories based?

Genes Laboratories is headquartered in Yongin, South Korea, in the Asia region.

How does Genes Laboratories make money?

Three revenue lines are on record. Human Diagnostic Kits are the primary driver. The others are veterinary Diagnostic Kits and PCR Raw Materials and Reagents.

Who are Genes Laboratories's main competitors?

Broad incumbents on record are Hologic (Panther Fusion), Qiagen, Roche Diagnostics, Cepheid (Danaher) and bioMérieux (BioFire). Direct peers are Kogene Biotech, Seegene, SD Biosensor and SolGent (SolGent Daejeon). Bioneer is listed as an emerging player.

Does Genes Laboratories have an API?

No public API is recorded for Genes Laboratories.

What industry is Genes Laboratories in?

Genes Laboratories's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales